Successful treatment of actinic prurigo with baricitinib in an 8-year-old child: A case report

Mohammad Malekan; Nessa Aghazadeh Mohandesi; Ghasem Rahmatpour Rokni; Mahsa Babaei; Fatemeh Montazer; Nasim Gholizadeh

doi:10.1111/pde.15643

Successful treatment of actinic prurigo with baricitinib in an 8-year-old child: A case report

Pediatr Dermatol. 2024 Apr 29. doi: 10.1111/pde.15643. Online ahead of print.

Authors

Mohammad Malekan¹, Nessa Aghazadeh Mohandesi², Ghasem Rahmatpour Rokni³, Mahsa Babaei⁴, Fatemeh Montazer⁵, Nasim Gholizadeh³

Affiliations

¹ Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
² Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
⁴ School of Medicine, Stanford University, Stanford, California, USA.
⁵ Department of Pathology, Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran.

PMID: 38684232
DOI: 10.1111/pde.15643

Abstract

Actinic prurigo is a rare photodermatosis characterized by pruritic papulonodular lesions. Treatment is challenging, especially in children, as sun protection strategies need to be rigorously implemented and symptoms often persist throughout the year. Herein, we present a case of actinic prurigo in an 8-year-old patient with rapid and successful relief with baricitinib.

Keywords: Janus kinase inhibitors; actinic prurigo; baricitinib; photodermatosis.

Publication types

Case Reports